Sensitization to HY-Antigen in Female Donors Was Not Associated with the Post-Transplant HY-IgG Development Nor Clinical Outcomes in Sex-Mismatched Transplantation

Abstract

results suggest that post-transplant IL-22 administration represents a novel strategy to reduce gut GVHD by direct protection of intestinal epithelium without limiting immune function post-transplant.